4//SEC Filing
PISKEL KYLE 4
Accession 0001062993-25-004813
CIK 0001478320other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 7:20 PM ET
Size
9.2 KB
Accession
0001062993-25-004813
Insider Transaction Report
Form 4
PISKEL KYLE
Chief Financial Officer
Transactions
- Award
Common Stock
2025-03-04+125,000→ 279,330 total - Sale
Common Stock
2025-03-05$6.97/sh−3,103$21,628→ 276,227 total - Sale
Common Stock
2025-03-05$6.98/sh−253$1,766→ 275,974 total - Sale
Common Stock
2025-03-05$6.99/sh−6,964$48,678→ 269,010 total
Footnotes (1)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780662
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 7:20 PM ET
- Size
- 9.2 KB